Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Contineum Therapeutics, Inc. (CTNM) had Weighted-Average Shares Outstanding (Diluted) of 37.47M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-15.15M |
|
-- |
|
-- |
|
$17.43M |
|
$-17.43M |
|
$2.27M |
|
$-15.15M |
|
$-15.15M |
|
$-15.15M |
|
$-15.15M |
|
$-15.15M |
|
$-15.15M |
|
$-17.43M |
|
$-17.29M |
|
37.47M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
37.47M |
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$242.58M |
|
$0.93M |
|
$7.79M |
|
$250.37M |
|
$6.53M |
|
-- |
|
$4.18M |
|
$10.71M |
|
$239.66M |
|
$239.66M |
|
$239.66M |
|
37.61M |
|
| Cash Flow Statement Financials | |
$-27.77M |
|
$-34.45M |
|
$1.33M |
|
$75.60M |
|
$14.71M |
|
$-60.89M |
|
$7.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
37.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-28.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-6.32% |
|
-6.32% |
|
-6.05% |
|
-6.32% |
|
$6.37 |
|
$-0.75 |
|
$-0.74 |
|